Skip to main content
S 3345 116th Congress Senate Government Operations and Politics Accounting and auditing Border security and unlawful immigration Customs enforcement Department of Homeland Security Drug trafficking and controlled substances Government employee pay, benefits, personnel management Government studies and investigations Health promotion and preventive care Health technology, devices, supplies Law enforcement officers Mammals Service animals Worker safety and health

Synthetic Opioid Exposure Prevention and Training Act

Introduced: February 27, 2020 Introduced by: Peters, Gary C. Democratic · Michigan See on congress.gov
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 27, 2020
Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
Feb 27, 2020
Introduced in Senate
 Plain-English summary Congressional Research Service

Synthetic Opioid Exposure Prevention and Training Act

This bill directs the U.S. Customs and Border Protection (CBP) to implement a safety framework to protect its personnel from exposure to potential synthetic opioids.

Among other things, the CBP must do the following:

  • issue a policy that specifies protocols and procedures for the safe handling of potential synthetic opioids;
  • require mandatory training on the potential risk of exposure to and safe handling procedures for synthetic opioids, as well as how to administer opioid receptor antagonists (e.g., naloxone) after exposure; and
  • provide personal protective equipment and opioid receptor antagonists to officers, agents, other personnel, and canines at risk of exposure to synthetic opioids.
What's happening now February 27, 2020

Read twice and referred to the Committee on Homeland Security and Governmental Affairs.

 Committees of jurisdiction 1